Selexipag vs placeboPVR · pulmonary arterial hypertension1 finding from 1 reviewProstacyclin for pulmonary arterial hypertension 2019 · Cochrane Headline outcomes onlyno estimate extracted1 study · 43 participantsModerate
Prostacyclin vs controlPVR · pulmonary arterial hypertension1 finding from 1 reviewProstacyclin for pulmonary arterial hypertension 2019 · Cochrane Headline outcomes onlyno estimate extracted7 studies · 658 participantsModerate